- Lusutrombopag
-
- $68.00 / 1mg
-
2025-04-28
- CAS:1110766-97-6
- Min. Order:
- Purity: 99.96%
- Supply Ability: 10g
- Lusutrombopag
-
- $0.00 / 1g
-
2025-01-13
- CAS:1110766-97-6
- Min. Order: 1g
- Purity: More Than 99%
- Supply Ability: 100kg/Month
- Lusutrombopag
-
- $10.00 / 1kg
-
2024-05-13
- CAS:1110767-00-7
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: g-kg-tons, free sample is available
|
| | Lusutrombopag Basic information |
| Product Name: | Lusutrombopag | | Synonyms: | Lusutrombopag S-888711;(E)-3-[2,6-dichloro-4-[4-[3-[(S)-1-hexyloxyethyl]-2-methoxyphenyl]thiazol-2-ylcarbamoyl]phenyl]-2-methylacrylic acid;S 888711;S888711;S888711;S 888711;2-Propenoic acid, 3-[2,6-dichloro-4-[[[4-[3-[(1S)-1-(hexyloxy)ethyl]-2-methoxyphenyl]-2-thiazolyl]amino]carbonyl]phenyl]-2-methyl-, (2E)-;Lusutrombopag,inhibit,Inhibitor,S888711,S 888711,Thrombopoietin Receptor;Rutroppa | | CAS: | 1110766-97-6 | | MF: | C29H32Cl2N2O5S | | MW: | 591.55 | | EINECS: | | | Product Categories: | API | | Mol File: | 1110766-97-6.mol |  |
| | Lusutrombopag Chemical Properties |
| density | 1.299±0.06 g/cm3(Predicted) | | solubility | DMSO: 30 mg/ml | | form | A crystalline solid | | pka | 4.33±0.21(Predicted) | | color | White to off-white | | InChIKey | NOZIJMHMKORZBA-KJCUYJGMSA-N | | SMILES | C(O)(=O)/C(/C)=C/C1=C(Cl)C=C(C(NC2=NC(C3=CC=CC([C@@H](OCCCCCC)C)=C3OC)=CS2)=O)C=C1Cl |
| | Lusutrombopag Usage And Synthesis |
| Uses | Lusutrombopag is a newly discovered thrombopoietin receptor agonist used in the treatment of patients with chronic ITP. | | Definition | ChEBI: Lusutrombopag is a member of cinnamic acids. | | Mechanism of action |
Lusutrombopag acts selectively on the human TPO receptor and activates signal transduction pathways that promote the proliferation and differentiation of bone marrow cells into megakaryocytes, thereby increasing platelet levels.
|
| | Lusutrombopag Preparation Products And Raw materials |
|